Pearson’s Clinical Assessment
Pearson's Clinical Assessment, a division of Pearson plc, develops and distributes validated psychological, neuropsychological, and educational assessment instruments via Q-global, Q-interactive, and Q Local platforms for healthcare providers, K-12 schools, universities, government agencies, and pharmaceutical researchers.
- Company typePublic
- Founded1996
- HeadquartersSan Antonio, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What Pearson’s Clinical Assessment does
Pearson's Clinical Assessment is a U.S.-headquartered operating division of Pearson plc (LSE: PSON) that develops, validates, and distributes standardized psychological, neuropsychological, educational, and clinical assessment instruments for licensed practitioners and institutions. Its portfolio spans cognition/neuro, academic learning, behavior, developmental/early childhood, motor/sensory, personality/biopsychosocial, speech/language, career planning, MTSS/RTI benchmarking, and Spanish-language assessments, available in both digital and print formats. The product architecture is built around three core delivery platforms — Q-global (web-based administration, scoring, and reporting), Q-interactive (1:1 iPad-based administration), and Q Local (desktop scoring and reporting) — with adjacent modules including aimswebPlus, Review360, Digital Assessment Libraries segmented by buyer (Healthcare, K-12, Universities), and a Telepractice platform for remote administration.
Revenue is generated through four streams: one-time assessment kit and instrument sales, recurring SaaS subscriptions on the Q-platforms, professional learning and training services (Professional Learning courses, Training Partner Program, Per-User Learning), and specialized pharma research services supporting clinical trials and neurological research. Go-to-market combines enterprise field sales to healthcare providers, school districts, universities, and government/public safety agencies with a qualifications-gated e-commerce storefront for direct professional purchases; international buyers are routed through regional offices. The division serves five principal verticals — Healthcare Providers and Clinical Practitioners (primary), K-12 Education (primary), Higher Education, Government and Public Safety, and Pharmaceutical Research — and holds approximately 38.4% North American share of the cognitive assessment market, which is forecast to grow at 8.8% CAGR through 2036. Competitive advantages rest on the depth of validated normative data, practitioner training infrastructure, and multi-channel distribution rather than on proprietary AI/ML capability, which is not evidenced in available materials.
Pearson’s Clinical Assessment firmographics
Firmographics- Name
- Pearson’s Clinical Assessment
- Legal name
- Pearson
- Website
- https://pearsonclinical.com
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Pearson's Clinical Assessment, a division of Pearson plc, develops and distributes validated psychological, neuropsychological, and educational assessment instruments via Q-global, Q-interactive, and Q Local platforms for healthcare providers, K-12 schools, universities, government agencies, and pharmaceutical researchers.
- Ownership category
- akta.pro rank
Pearson’s Clinical Assessment industry classification
Industry- Product category
- Clinical and Educational Assessment Software
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Educational Services (8200)
- akta.pro primary industry
- Diagnostic & Adaptive Assessment Content (Skills/Readiness) (EDAGADAJ)
- akta.pro secondary industries
- Assessment, Testing & Analytics Platforms (Formative/Summative) (EDAJAMAC), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)
Keywords
Where Pearson’s Clinical Assessment is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Pearson’s Clinical Assessment business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain
Revenue model
- Assessment Tool Sales: Sale of clinical and educational assessment instruments across multiple domains including cognitive, behavioral, developmental, speech/language, and personality assessments. Products available in both digital and print formats.
- Digital Platform Subscriptions: Recurring subscription revenue from Q-global, Q-interactive, and Q Local platforms that provide web-based and iPad-based assessment administration, scoring, and reporting services.
- Professional Learning and Training: Training services including Professional Learning courses, Training Partner Program (TPP), and Per-User Learning offerings for practitioners seeking to enhance assessment competencies.
- Pharma Research Services: Specialized services for pharmaceutical research including clinical trials support, providing assessment tools and expertise for drug development and neurological research.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Pearson’s Clinical Assessment product offering
Product offeringCore offering
Pearson's Clinical Assessment develops and sells psychometrically validated clinical and educational assessment instruments, delivered through its proprietary Q-global (web-based), Q-interactive (iPad-based), and Q Local (offline) platforms, covering cognitive, behavioral, developmental, academic learning, speech/language, personality/biopsychosocial, motor/sensory, career planning, and Spanish-language assessments. The offering also includes add-on solutions such as aimswebPlus, Review360, sector-specific Digital Assessment Libraries (Healthcare, K-12, Universities), Telepractice, and Professional Learning/Training services for qualified practitioners in healthcare, education, government, and pharmaceutical research.
Product overview
Pearson Clinical Assessment provides a comprehensive portfolio of professional psychological, educational, and therapy assessment tools available in both digital and print formats. The offering operates as a platform-plus-modules architecture centered around three primary digital delivery platforms: Q-global (web-based administration, scoring, and reporting), Q-interactive (iPad-based 1:1 assessment system), and Q Local (local software for scoring and reporting). These platforms serve as the infrastructure through which hundreds of specific assessments are delivered across major categories including Cognition/Neuro, Academic Learning, Behavior, Developmental/Early Childhood, Personality & Biopsychosocial, Speech & Language, Motor/Sensory, Career Planning, and MTSS/RTI/Benchmarking. Add-on solutions like aimswebPlus, Review360, and the Digital Assessment Library suites extend functionality for specific use cases. The company also offers Professional Learning and Training services including the Training Partner Program (TPP) and Per-User Training options, along with research engagement opportunities through the Research Engagement Portal. Assessment tools are available in multiple languages including Spanish, and digital solutions include Telepractice capabilities for remote administration.
Differentiator
Problem solved
Functional benefit
Brands
- Q-global: Web-based administration, scoring, and reporting platform for assessments
- Q-interactive
- Q Local
- aimswebPlus
- Review360
- Digital Assessment Library
Products and services
- Q-global Web-based platform for administration, scoring, and reporting of Pearson's professional assessments; provides cloud-based access to clinical and educational assessment tools for qualified practitioners.
- Q-interactive
- Q Local
- aimswebPlus
- Digital Assessment Library for Healthcare
- Digital Assessment Library for Schools (K-12)
- Digital Assessment Library for Universities
- Review360
- Telepractice
- Academic Learning Assessments
- Behavior Assessments
- Cognition / Neuro Assessments
- Personality & Biopsychosocial Assessments
- Speech & Language Assessments
- Developmental / Early Childhood Assessments
- Career Planning Assessments
- Motor / Sensory Assessments
- MTSS/RTI/Benchmarking Assessments
- Spanish Assessments
- Professional Learning
- Training Partner Program (TPP)
- Per-User Training
- Research Engagement Portal
Companies that use Pearson’s Clinical Assessment
Customer profileSegments5 records
Ideal customer profiles5 records
Pearson’s Clinical Assessment technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Pearson’s Clinical Assessment partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
Pearson’s Clinical Assessment competitors and assessment
Company assessmentRegional players
- Schuhfried: European-based publisher of psychological and neuropsychological assessments (e.g., Vienna Test System). Comparable product offering but primarily serving European markets — a regional complement to Pearson's North American dominance.
Direct peers
- Riverside Insights: Provider of K-12 and clinical assessments including CogAT and Iowa Assessments. Directly competes with Pearson's K-12 portfolio (aimswebPlus, MTSS/RTI tools) and selected clinical products.
- Multi-Health Systems (MHS): Publishes validated psychological assessments including the Conners and ASRS tools. Directly competes with Pearson in clinical assessment products used by healthcare practitioners and schools.
- PAR (Psychological Assessment Resources): Direct competitor publishing clinical psychological and educational assessments used by psychologists, schools, and clinicians. Overlaps with Pearson across cognitive, behavioral, and personality assessment categories.
- Cogstate: Directly competes in computerized cognitive assessment with strong presence in clinical trials, healthcare, and research markets. Identified alongside Pearson as one of three dominant players in the global cognitive assessment market.
- Cambridge Cognition: Directly competes with Pearson in cognitive assessment, particularly for clinical trials and pharmaceutical research. Named alongside Pearson as a top-three global cognitive assessment platform provider per market commentary.
- Western Psychological Services (WPS): Publishes psychological, neuropsychological, and educational assessments with comparable digital delivery. Competes with Pearson across clinical and school-based assessment categories.
Broad incumbents
- Educational Testing Service (ETS): Large established assessment organization operating across K-12, higher education, and professional certification. While broader in scope, ETS competes with Pearson in selected K-12 and clinical/research assessment adjacencies.
Emerging players
- ImPACT Applications: Specializes in computerized cognitive testing for concussion assessment and baseline testing. Competes in an overlapping niche of computerized cognitive testing used by clinicians and public safety organizations.
- Creyos (formerly Cambridge Brain Sciences): Digital-native cognitive assessment platform focused on healthcare and research use cases. Represents the cloud-first competitive threat to Pearson's Q-global/Q-interactive stack with modern UX and lower price points.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Pearson’s Clinical Assessment social profiles
Digital presencePearson’s Clinical Assessment financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pearson’s Clinical Assessment leadership team
Management profileNumber of profiles
Pearson’s Clinical Assessment funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pearson’s Clinical Assessment M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pearson’s Clinical Assessment
What does Pearson’s Clinical Assessment do?
Pearson's Clinical Assessment develops and sells psychometrically validated clinical and educational assessment instruments, delivered through its proprietary Q-global (web-based), Q-interactive (iPad-based), and Q Local (offline) platforms, covering cognitive, behavioral, developmental, academic learning, speech/language, personality/biopsychosocial, motor/sensory, career planning, and Spanish-language assessments. The offering also includes add-on solutions such as aimswebPlus, Review360, sector-specific Digital Assessment Libraries (Healthcare, K-12, Universities), Telepractice, and Professional Learning/Training services for qualified practitioners in healthcare, education, government, and pharmaceutical research.
Is Pearson’s Clinical Assessment a public or private company?
Pearson’s Clinical Assessment is a public company. It is classified as corporate owned and is currently operating.
When was Pearson’s Clinical Assessment founded?
Pearson’s Clinical Assessment was founded in 1996. It employs 1,001 to 5,000 people.
Where is Pearson’s Clinical Assessment based?
Pearson’s Clinical Assessment is headquartered in San Antonio, United States, in the North America region.
How does Pearson’s Clinical Assessment make money?
Four revenue lines are on record. Assessment Tool Sales are the primary driver. The others are digital Platform Subscriptions, professional Learning and Training and pharma Research Services.
Who are Pearson’s Clinical Assessment's main competitors?
Schuhfried is listed as a regional player. Direct peers are Riverside Insights, Multi-Health Systems (MHS), PAR (Psychological Assessment Resources), Cogstate, Cambridge Cognition and Western Psychological Services (WPS). Educational Testing Service (ETS) is listed as a broad incumbent. Emerging players are ImPACT Applications and Creyos (formerly Cambridge Brain Sciences).
Does Pearson’s Clinical Assessment have an API?
No public API is recorded for Pearson’s Clinical Assessment.
What industry is Pearson’s Clinical Assessment in?
Pearson’s Clinical Assessment's product category is Clinical and Educational Assessment Software. Its primary akta.pro industry code is EDAGADAJ, Diagnostic & Adaptive Assessment Content (Skills/Readiness), with a secondary code of EDAJAMAC, Assessment, Testing & Analytics Platforms (Formative/Summative). Its NAICS code is 54169 and its SIC code is 8200.